Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;75(5):1177-1186.
doi: 10.1007/s43440-023-00528-7. Epub 2023 Sep 12.

HDAC3 inhibition protects against peripheral and central alterations in an animal model of obesity

Affiliations

HDAC3 inhibition protects against peripheral and central alterations in an animal model of obesity

Franciéle Romero Machado et al. Pharmacol Rep. 2023 Oct.

Abstract

Background: Obesity is a multifactorial disease with epigenetic manifestations that increases the prevalence of associated comorbidities such as metabolic syndrome, cardiovascular dysfunction, and major depression disorder. Given the aforementioned, a search for new pharmacological alternatives for the treatment of this disease is necessary. The current study aimed to evaluate the effects of histone deacetylase-3 (HDAC3) inhibition caused by RGFP966 (a benzamide-type HDAC inhibitor selective for HDAC3) administration, in an animal model of obesity induced by high-fat diet (HFD).

Methods: Adult male mice C57BJ/6 were fed with a normal pellet diet (NPD) or HFD for 120 days. The HDAC3 inhibitor (RGFP966; 10 mg/kg; sc) was administered on the 91st to 120th day of the experiment (per 30 days). After the last inhibitor administration, animals were euthanized, blood was collected, and the hippocampus was removed for biochemical determinations.

Results: In an overall manner, the administration of RGFP966 protected against changes in body weight gain, glucose, insulin, lipid profile, adipokines, and increase of hippocampal proinflammatory cytokines levels caused by HFD.

Conclusion: Therefore, HDAC3 inhibition can represent a promising pharmacological target for the treatment of obesity.

Keywords: Epigenetic; Metabolism; Neuroinflammation; Nutrition; Obesity.

PubMed Disclaimer

Similar articles

References

    1. Santilli F, Boskovic A. Mechanisms of transgenerational epigenetic inheritance: lessons from animal model organisms. Curr Opin Genet Dev. 2023;79: 102024. - DOI - PubMed
    1. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, et al. New nomenclature for chromatin-modifying enzymes. Cell. 2007;131:633–6. - DOI - PubMed
    1. Athaide Rocha KM, Machado FR, Poetini M, Giacomeli R, Boeira SP, Jesse CR, et al. Assessment of suberoylanilide hydroxamic acid on Alzheimer’s disease model induced by β-amyloid(1–42) in aged female mice: neuromodulatory and epigenetic effect. Chem Biol Interact. 2023;375: 110429. - DOI - PubMed
    1. Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6: a018713. - DOI - PubMed - PMC
    1. Bai L, Pang WJ, Yang YJ, Yang GS. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem. 2008;307:129–40. - DOI - PubMed